Retinoids and human breast cancer: In vivo effects of an antagonist for RAR-α

Cancer Letters

Volumn 219, Issue 1, 2005, Pages 27-31

  Toma, Salvatore ^a,b   Emionite, Laura ^a   Scaramuccia, Angelo ^a   Ravera, Giambattista ^a   Scarabelli, Linda ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Breast cancer; RAR selective antagonist Ro 41 5253; Retinoids

Indexed keywords

ANTINEOPLASTIC AGENT; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RO 41 5253; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GRAFT; CANCER INHIBITION; CANCER MODEL; CELL GROWTH; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG SCREENING; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

ANIMALIA;

EID: 13444259610     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.018     Document Type: Article

References (27)

1. M.B. Sporn, A.B. Roberts, and D.W.S. Goodman second ed. The Retinoids, Biology, Chemistry and Medicine 1994 Raven Press New York
2. C. Thaller, and G. Eichele Identification and spatial distribution of retinoids in the developing chick limb bud Nature 327 1987 625 628
3. S.M. Lippman, and R. Lotan Advances in the development of retinoids as chemopreventive agents J. Nutr. 130 2000 479S 482S
4. R.C. Moon, and R.G. Mehta Chemoprevention of mammary cancer by retinoids Basic Life Sci. 52 1990 213 224
5. P. Prakash, R.M. Russell, and N.I. Krinsky In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids J. Nutr. 131 2001 1574 1580
6. I. Klaassen, and B.J. Braakhuis Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer Oral Oncol. 38 2002 532 542
7. M. Petkovich, N.J. Brand, A. Krust, and P. Chambon A human retinoic acid receptor which belongs to the family of nuclear receptors Nature 330 1987 444 450
8. V. Giguere, E.S. Ong, P. Segui, and R.M. Evans Identification of a receptor for the morphogen retinoic acid Nature 330 1987 624 629
9. P. Leroy, A. Krust, P. Kastner, C. Mendelsohn, A. Zelent, and P. Chambon Retinoic acid receptors G. Morris-Kay Retinoids in Normal Development and Teratogenesis 1992 Oxford University Press Oxford 7 25
10. D.J. Mangelsdorf, and R. Evans Vitamin A receptors: new insight on retinoid control of transcription G. Morris-Kay Retinoids in Normal Development and Teratogenesis 1992 Oxford University Press Oxford 7 25
11. X.K. Zhang, and M. Pfahl Regulation of retinoid and thyroid action through homo- and heterodimeric receptors Trends Endocrinol. Metab. 4 1993 156 162
12. M.E. Huang, Y.C. Ye, S.R. Chen, J.R. Chai, J.X. Lu, and L. Zhoa Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood 72 1988 567 572
13. E.J. Lammer, D.T. Chen, R.M. Hoar, N.D. Agnish, P.J. Benke, and J.T. Braun Retinoic acid embryopathy N. Engl. J. Med. 313 1985 837 841
14. F. Chytil Retinoic acid: biochemistry, pharmacology, toxicology and therapeutic use Pharmacol. Rev. 36 1984 93 100
15. M.A. Smith, D.R. Parkinson, B.D. Cheson, and M. Friedman Retinoids in cancer therapy J. Clin. Oncol. 10 1992 839 864
16. C.E. Orfanos, R. Ehlert, and H. Gollnick The retinoids. A review of their clinical pharmacology and therapeutic use Drugs 34 1987 459 503
17. S. Toma, L. Isnardi, P. Raffo, L. Riccardi, G. Dastoli, and C. Apfel RAR-α antagonist Ro 41-5253 inhibits proliferation and induces apoptosis in breast cancer cell lines Int. J. Cancer 78 1998 86 94
18. A. Fanjul, M.I. Dawson, P.D. Hobbs, L. Jong, J.F. Cameron, and G. Graupner A new class of retinoids with selective inhibition of AP-1 inhibits proliferation Nature 372 1994 107 111
19. K. Eckhardt, and G. Schmitt A retinoic acid receptor alpha antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo Toxicol. Lett. 70 1994 299 308
20. M.F. El Etreby, and Y. Liang Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice Breast Cancer Res. Treat. 49 1998 109 117
21. M. Pfahl Nuclear receptor/AP-1 interaction Endocr. Rev. 14 1993 651 658
22. P. Angel, and M. Karin The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim. Biophys. Acta 1072 1991 129 157
23. X.F. Zhou, X.Q. Shen, and L. Shemshedini Ligand-activated retinoic acid receptors inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization Mol. Endocrinol. 13 1999 276 285
24. R. Schule, P. Rangarajan, N. Yang, S. Kliewer, L.J. Ransone, and J. Bolado Retinoic acid is a negative regulator of AP-1-responsive genes Proc. Natl Acad. Sci. USA 88 1991 6092 6096
25. G. Salbert, A. Fanjul, F.J. Piedrafita, X.P. Lu, S.J. Kim, P. Tran, and M. Pfahl Retinoic acid receptors and retinoid X-receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity Mol. Endocrinol. 7 1993 1347 1356
26. J.Y. Chen, S. Penco, J. Ostrowski, P. Balaguer, M. Pons, and J.E. Starrett RAR-specific agonist/antagonists which dissociate transactivation and AP-1 transrepression inhibit anchorage-independent cell proliferation Eur. Mol. Biochem. Org. J. 14 1995 1187 1197
27. C.T. Guy, M.A. Webster, M. Schaller, T.J. Parsons, R.D. Cardiff, and W.J. Muller Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc. Natl Acad. Sci. USA 89 1992 10578 10582